Edward Carr, Chief Accounting Officer: Dianthus Therapeutics DNTH Sell · Filed 03/13

Trade details

Type: Insider sale
Amount: $1,279,414.92
Shares · price: 15,852 sh · $80.71 a share
Held after: 27,830 sh
Stock: Dianthus Therapeutics DNTH
Person: Edward CarrChief Accounting Officer
Trade date: 26/03/12
Filed: 26/03/13
Days to filing: 1 days

Sold 36.3% of holdings

Share of holding sold: 36.3%

Dianthus Therapeutics trades, last 26 weeks

What else happened in Dianthus Therapeutics around then

Filed or reported within 30 days of the trade day · 02/10~04/11

Edward Carr's recent trades

Edward CarrChief Accounting Officer
Planned sale10b5-1 planDianthus Therapeutics
Planned sale10b5-1 plan
Dianthus Therapeutics
DNTH
$2M
20,000 sh
$2M
Filed 09/17
Traded 09/17
Edward CarrChief Accounting Officer
Sell10b5-1 planDianthus Therapeutics
Sell10b5-1 plan
Dianthus Therapeutics
DNTH
$1.9M
23,465 sh
$1.9M
Filed 03/13
Traded 03/12
Edward CarrChief Accounting Officer
Sell10b5-1 planDianthus Therapeutics
Sell10b5-1 plan
Dianthus Therapeutics
DNTH
$319.5K
3,865 sh
$319.5K
Filed 03/13
Traded 03/12
Edward CarrChief Accounting Officer
Sell10b5-1 planDianthus Therapeutics
Sell10b5-1 plan
Dianthus Therapeutics
DNTH
$25.7K
300 sh
$25.7K
Filed 03/13
Traded 03/12
Edward CarrChief Accounting Officer
Sell10b5-1 planDianthus Therapeutics
Sell10b5-1 plan
Dianthus Therapeutics
DNTH
$16.7K
200 sh
$16.7K
Filed 03/13
Traded 03/12

Edward Carr, CAO — sold $1.3M of Dianthus Therapeutics DNTH · 36.3% of holdings · 10b5-1 plan | Whalegun